Cargando…

Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension

Detalles Bibliográficos
Autores principales:	Kallianos, Kimberly, Brooks, Gabriel, Higgins, Charles, Ordovas, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328797/ http://dx.doi.org/10.1186/1532-429X-17-S1-P380

Ejemplares similares

Left ventricular myocardial deformation measurements by magnetic resonance Tissue Tracking agrees with tagging (HARP) in healthy volunteers
por: Mukai, Kanae, et al.
Publicado: (2016)

Late gadolinium enhancement in pulmonary hypertension predicts clinical events
por: Soma, Siva Kumar, et al.
Publicado: (2012)

Myocardial fibrosis with T1 mapping and right ventricular performance in pulmonary hypertension
por: Garcia-Lunar, Ines, et al.
Publicado: (2013)

Extent of late gadolinium enhancement in patients with hypertrophic cardiomyopathy in correlation with serum MMP9 as an indicator of myocardial fibrosis
por: Avanesov, Maxim, et al.
Publicado: (2014)

Quantifying myocardial fibrosis in hypertensive left ventricular hypertrophy using T1 mapping
por: Janardhanan, Rajesh, et al.
Publicado: (2012)

Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium Eenhancement
por: Soslow, Jonathan H, et al.
Publicado: (2016)

SSFP cine images early post-gadolinium improve detection of myocardial oedema in acute myocardial infarction compared to T2-weighted dark blood turbo spin echo images
por: Chan, Winnie, et al.
Publicado: (2012)

Myocardial fibrosis detected with gadolinium delayed enhancement in cardiac magnetic resonance imaging is related with arterioventricular coupling alterations in patients with acute myocarditis
por: Chrysohoou, Christina, et al.
Publicado: (2015)

Three-compartment (3C) pharmacokinetic modeling is more accurate than two-compartment (2C) modeling of myocardial fibrosis gadolinium kinetics
por: Goldfarb, James W, et al.
Publicado: (2012)

Use of non-contrast Myocardial T1 times to distinguish between fibrosis and normal myocardial tissue, a possible alternative for patients who cannot receive gadolinium-based contrast agents
por: Addetia, Karima, et al.
Publicado: (2016)

Cardiac magnetic resonance left ventricular quantitative analysis post gadolinium: reliable and reproducible?
por: Rofe, Christopher J, et al.
Publicado: (2011)

Quantification of acute myocardial injury in STEMI patients post revascularization at 3Tesla. Comparison of T1-mapping, late gadolinium and edema imaging
por: Erica, Dall'Armellina, et al.
Publicado: (2011)

A new method for objective myocardial scar characterization using MR late gadolinium enhancement and post-contrast look-locker sequences
por: Tao, Qian, et al.
Publicado: (2013)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Comparison of the amount of affected myocardium quantified by late gadolinium enhancement and the degree of myocardial necrosis measured by cardiac troponin T in patients with myocarditis
por: Andre, Florian, et al.
Publicado: (2013)

Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: proof of additional diagnostic value compared to conventional late gadolinium enhancement (LGE) imaging
por: Florian, Anca, et al.
Publicado: (2014)

Myocardial late gadolinium enhancement in systemic lupus erythematosus as a marker of chronic inflammation
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

The incidence and prognostic value of silent myocardial scar by late gadolinium enhancement in patients with atrial fibrillation
por: Neilan, Tomas G, et al.
Publicado: (2013)

Improved prediction of adverse events in hypertrophic cardiomyopathy with quantitative late gadolinium enhancement and myocardial strain
por: Brahmanandam, Vikram, et al.
Publicado: (2016)

Microstructural remodeling in the post-infarct porcine heart measured by diffusion tensor MRI and T1-weighted late gadolinium enhancement MRI
por: Kung, Geoffrey L, et al.
Publicado: (2012)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2013)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2009)

Characterization of myocardial T(1) and partition coefficient as a function of time after gadolinium delivery in healthy subjects
por: Chow, Kelvin, et al.
Publicado: (2011)

Extracellular volume MRI increases the detection of myocardial abnormalities beyond late gadolinium enhancement - initial findings
por: Lundin, Magnus, et al.
Publicado: (2012)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

Increase of myocardial infarctions over the years after heart transplantation detected by late gadolinium enhanced MRI
por: Braggion Santos, Maria Fernanda, et al.
Publicado: (2013)

Infarct delineation in patients with acute myocardial infarction using the tractographic propagation angle and late gadolinium enhancement
por: Mekkaoui, Choukri, et al.
Publicado: (2015)

Is signal intensity of late gadolinium enhancement a substitute for extracellular volume mapping in acute myocardial infarction?
por: Garg, Pankaj, et al.
Publicado: (2015)

Extracellular volume fractions are not consistent in gray zones determined by late gadolinium enhancement imaging of myocardial infarction
por: Parikh, Paras, et al.
Publicado: (2016)

Assessment of myocardial viability in low signal intensity areas on cine MRI comparison with late gadolinium enhancement imaging in patients with prior myocardial infarction
por: Tanimoto, Takashi, et al.
Publicado: (2012)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

Dobutamine in acute myocardial infarction: should we use it for reduction of pulmonary hypertension and pulmonary capillary wedge pressure in acute myocardial infarction?
por: Macas, A, et al.
Publicado: (2008)

Focal myocardial fibrosis detected with magnetic resonance late Gadolinium enhancement imaging and diffuse interstitial fibrosis determined with histological staining of endomyocardial biopsy specimens in patients with non-ischemic left ventricular systolic dysfunction: two distinct entities?
por: Schalla, Simon, et al.
Publicado: (2009)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Detection and prevalence of myocardial infarction early and late after heart transplantation detected by late gadolinium enhanced MRI
por: Steen, Henning, et al.
Publicado: (2012)

Magnetic resonance evaluation of coronary anatomy, first-pass myocardial perfusion and late gadolinium enhancement in children with acquired and congenital heart disease
por: Adebo, Dilachew, et al.
Publicado: (2015)

Validation of early myocardial gadolinium enhancement (EGE) evaluation with "Lake Louise consensus" criteria in patients with suspected myocarditis using a single bolus of 0.1 mmol/Kg of a high relaxivity gadolinium-based contrast agent
por: Galea, Nicola, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7p9j601ep24987u7sunr30cef8